Omnicell, Inc. (FRA:OC9)

Market Cap	1.28B +6.1%
Revenue (ttm)	1.09B +8.5%
Net Income	34.21M +69.3%
EPS	0.74 +70.7%
Shares Out	n/a
PE Ratio	37.47
Forward PE	16.75
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	28.00
Previous Close	28.20
Day's Range	27.80 - 28.00
52-Week Range	25.00 - 43.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About Omnicell

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-hous...

• Industry: Special Industry Machinery, not elsewhere classified
• Founded: 1992
• Employees: 3,485
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: OC9

Financial Performance

In 2025, Omnicell's revenue was $1.18 billion, an increase of 6.53% compared to the previous year's $1.11 billion. Earnings were $2.05 million, a decrease of -83.62%.

Financial numbers in USD

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 20, 2026

Data Sources Report a data error